AI-generated summary
The authors describe the incidence and severity of oral mucositis in 30 patients undergoing hematopoietic cell transplantation who received daily low-level laser phototherapy at 660 nm. Most patients had grade I or II mucositis, and no patients had grade III or IV disease on the most critical post-transplant days. The authors note that the findings suggest a benefit but that randomized clinical trials are needed to confirm them.
- Participants
- 30
- Who or what was studied
- 30 patients undergoing hematopoietic cell transplantation (allogeneic or autologous)
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study is a survey of a small sample without a control group, and the authors state that randomized clinical trials are necessary to confirm the findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Power
- 40 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Phototherapy, GRADE, Oral mucositis. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.